NHS7108
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Aimmune Nestlé Health Science US R&D, LLC
Overview
NHS7108 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
NHS7108 clinical trials
Explore related
Medical disclaimer. This page summarizes research about NHS7108 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.